152 related articles for article (PubMed ID: 31858461)
1. Screening of Media Supplements for High-Performance Perfusion Cultures by Design of Experiment.
Mayrhofer P; Kunert R
Methods Mol Biol; 2020; 2095():27-39. PubMed ID: 31858461
[TBL] [Abstract][Full Text] [Related]
2. Development of Mammalian Cell Perfusion Cultures at Lab Scale: From Orbitally Shaken Tubes to Benchtop Bioreactors.
Wolf M; Morbidelli M
Methods Mol Biol; 2020; 2095():125-140. PubMed ID: 31858466
[TBL] [Abstract][Full Text] [Related]
3. Development of a shake tube-based scale-down model for perfusion cultures.
Wolf MKF; Lorenz V; Karst DJ; Souquet J; Broly H; Morbidelli M
Biotechnol Bioeng; 2018 Nov; 115(11):2703-2713. PubMed ID: 30039852
[TBL] [Abstract][Full Text] [Related]
4. Repurposing fed-batch media and feeds for highly productive CHO perfusion processes.
Kuiper M; Spencer C; Fäldt E; Vuillemez A; Holmes W; Samuelsson T; Gruber D; Castan A
Biotechnol Prog; 2019 Jul; 35(4):e2821. PubMed ID: 30985083
[TBL] [Abstract][Full Text] [Related]
5. Rapid development of clone-specific, high-performing perfusion media from established feed supplements.
Mayrhofer P; Reinhart D; Castan A; Kunert R
Biotechnol Prog; 2020 Mar; 36(2):e2933. PubMed ID: 31680446
[TBL] [Abstract][Full Text] [Related]
6. Process design and development of a mammalian cell perfusion culture in shake-tube and benchtop bioreactors.
Wolf MKF; Müller A; Souquet J; Broly H; Morbidelli M
Biotechnol Bioeng; 2019 Aug; 116(8):1973-1985. PubMed ID: 31038199
[TBL] [Abstract][Full Text] [Related]
7. Semi-continuous scale-down models for clone and operating parameter screening in perfusion bioreactors.
Bielser JM; Domaradzki J; Souquet J; Broly H; Morbidelli M
Biotechnol Prog; 2019 May; 35(3):e2790. PubMed ID: 30773840
[TBL] [Abstract][Full Text] [Related]
8. Platform development for high-throughput optimization of perfusion processes-Part II: Variation of perfusion rate strategies in microwell plates.
Dorn M; Lucas C; Klottrup-Rees K; Lee K; Micheletti M
Biotechnol Bioeng; 2024 Jun; 121(6):1774-1788. PubMed ID: 38433473
[TBL] [Abstract][Full Text] [Related]
9. Optimization of medium with perfusion microbioreactors for high density CHO cell cultures at very low renewal rate aided by design of experiments.
Schwarz H; Lee K; Castan A; Chotteau V
Biotechnol Bioeng; 2023 Sep; 120(9):2523-2541. PubMed ID: 37079436
[TBL] [Abstract][Full Text] [Related]
10. Small-scale bioreactor supports high density HEK293 cell perfusion culture for the production of recombinant Erythropoietin.
Schwarz H; Zhang Y; Zhan C; Malm M; Field R; Turner R; Sellick C; Varley P; Rockberg J; Chotteau V
J Biotechnol; 2020 Feb; 309():44-52. PubMed ID: 31891733
[TBL] [Abstract][Full Text] [Related]
11. Modulation and modeling of monoclonal antibody N-linked glycosylation in mammalian cell perfusion reactors.
Karst DJ; Scibona E; Serra E; Bielser JM; Souquet J; Stettler M; Broly H; Soos M; Morbidelli M; Villiger TK
Biotechnol Bioeng; 2017 Sep; 114(9):1978-1990. PubMed ID: 28409838
[TBL] [Abstract][Full Text] [Related]
12. Reduction of medium consumption in perfusion mammalian cell cultures using a perfusion rate equivalent concentrated nutrient feed.
Bielser JM; Kraus L; Burgos-Morales O; Broly H; Souquet J
Biotechnol Prog; 2020 Sep; 36(5):e3026. PubMed ID: 32415806
[TBL] [Abstract][Full Text] [Related]
13. Development and application of a high-throughput platform for perfusion-based cell culture processes.
Villiger-Oberbek A; Yang Y; Zhou W; Yang J
J Biotechnol; 2015 Oct; 212():21-9. PubMed ID: 26197419
[TBL] [Abstract][Full Text] [Related]
14. A protocol to transfer a fed-batch platform process into semi-perfusion mode: The benefit of automated small-scale bioreactors compared to shake flasks as scale-down model.
Janoschek S; Schulze M; Zijlstra G; Greller G; Matuszczyk J
Biotechnol Prog; 2019 Mar; 35(2):e2757. PubMed ID: 30479066
[TBL] [Abstract][Full Text] [Related]
15. Process performance and product quality in an integrated continuous antibody production process.
Karst DJ; Steinebach F; Soos M; Morbidelli M
Biotechnol Bioeng; 2017 Feb; 114(2):298-307. PubMed ID: 27497430
[TBL] [Abstract][Full Text] [Related]
16. Integrated continuous production of recombinant therapeutic proteins.
Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
[TBL] [Abstract][Full Text] [Related]
17. Development of a novel, high-throughput screening tool for efficient perfusion-based cell culture process development.
Gagliardi TM; Chelikani R; Yang Y; Tuozzolo G; Yuan H
Biotechnol Prog; 2019 Jul; 35(4):e2811. PubMed ID: 30932357
[TBL] [Abstract][Full Text] [Related]
18. Conversion of a CHO cell culture process from perfusion to fed-batch technology without altering product quality.
Meuwly F; Weber U; Ziegler T; Gervais A; Mastrangeli R; Crisci C; Rossi M; Bernard A; von Stockar U; Kadouri A
J Biotechnol; 2006 May; 123(1):106-16. PubMed ID: 16324762
[TBL] [Abstract][Full Text] [Related]
19. High-density mammalian cell cultures in stirred-tank bioreactor without external pH control.
Xu S; Chen H
J Biotechnol; 2016 Aug; 231():149-159. PubMed ID: 27320019
[TBL] [Abstract][Full Text] [Related]
20. Optimizing capacity utilization by large scale 3000 L perfusion in seed train bioreactors.
Pohlscheidt M; Jacobs M; Wolf S; Thiele J; Jockwer A; Gabelsberger J; Jenzsch M; Tebbe H; Burg J
Biotechnol Prog; 2013; 29(1):222-9. PubMed ID: 23225663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
